458 related articles for article (PubMed ID: 9076449)
21. Effect of laparoscopic and conventional colorectal resection on peritoneal fibrinolytic capacity: a prospective randomized clinical trial.
Neudecker J; Junghans T; Ziemer S; Raue W; Schwenk W
Int J Colorectal Dis; 2002 Nov; 17(6):426-9. PubMed ID: 12355220
[TBL] [Abstract][Full Text] [Related]
22. Overproduction of transforming growth factor-beta1 (TGF-beta1) is associated with adhesion formation and peritoneal fibrinolytic impairment.
Holmdahl L; Kotseos K; Bergström M; Falk P; Ivarsson ML; Chegini N
Surgery; 2001 May; 129(5):626-32. PubMed ID: 11331455
[TBL] [Abstract][Full Text] [Related]
23. Effect of Tisseel on expression of tissue plasminogen activator and plasminogen activator inhibitor-1.
Diamond MP; Kruger M; Saed GM
Fertil Steril; 2004 Jun; 81(6):1657-64. PubMed ID: 15193491
[TBL] [Abstract][Full Text] [Related]
24. [Can dexpanthenol prevent peritoneal adhesion formation? An experimental study].
Akdeniz Y; Tarhan OR; Barut I
Ulus Travma Acil Cerrahi Derg; 2007 Apr; 13(2):94-100. PubMed ID: 17682950
[TBL] [Abstract][Full Text] [Related]
25. Preoperative predictors of postsurgical adhesion formation and the Prevention of Adhesions with Plasminogen Activator (PAPA-study): results of a clinical pilot study.
Hellebrekers BW; Trimbos-Kemper TC; Boesten L; Jansen FW; Kolkman W; Trimbos JB; Press RR; van Poelgeest MI; Emeis SJ; Kooistra T
Fertil Steril; 2009 Apr; 91(4):1204-14. PubMed ID: 18353314
[TBL] [Abstract][Full Text] [Related]
26. Reduction of experimental adhesion formation by inhibition of plasminogen activator inhibitor type 1.
Falk K; Björquist P; Strömqvist M; Holmdahl L
Br J Surg; 2001 Feb; 88(2):286-9. PubMed ID: 11167882
[TBL] [Abstract][Full Text] [Related]
27. Peritoneal fluid and plasma fibrinolytic activity in women with pelvic inflammatory disease.
Dörr PJ; Brommer EJ; Dooijewaard G; Vemer HM
Thromb Haemost; 1992 Aug; 68(2):102-5. PubMed ID: 1412151
[TBL] [Abstract][Full Text] [Related]
28. Regulation of expression of tissue plasminogen activator and plasminogen activator inhibitor-1 by dichloroacetic acid in human fibroblasts from normal peritoneum and adhesions.
Diamond MP; El-Hammady E; Wang R; Kruger M; Saed G
Am J Obstet Gynecol; 2004 Apr; 190(4):926-34. PubMed ID: 15118614
[TBL] [Abstract][Full Text] [Related]
29. Response of visceral peritoneum to abdominal surgery.
Ivarsson ML; Falk P; Holmdahl L
Br J Surg; 2001 Jan; 88(1):148-51. PubMed ID: 11136330
[TBL] [Abstract][Full Text] [Related]
30. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
[TBL] [Abstract][Full Text] [Related]
31. Time to reconsider saline as the ideal rinsing solution during abdominal surgery.
Połubinska A; Winckiewicz M; Staniszewski R; Breborowicz A; Oreopoulos DG
Am J Surg; 2006 Sep; 192(3):281-5. PubMed ID: 16920418
[TBL] [Abstract][Full Text] [Related]
32. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
[TBL] [Abstract][Full Text] [Related]
33. Secretion of fibrinolytic enzymes facilitates human mesenchymal stem cell invasion into fibrin clots.
Neuss S; Schneider RK; Tietze L; Knüchel R; Jahnen-Dechent W
Cells Tissues Organs; 2010; 191(1):36-46. PubMed ID: 19390164
[TBL] [Abstract][Full Text] [Related]
34. Adenovirus-mediated overexpression of human tissue plasminogen activator prevents peritoneal adhesion formation/reformation in rats.
Atta HM; Al-Hendy A; El-Rehany MA; Dewerchin M; Abdel Raheim SR; Abdel Ghany H; Fouad R
Surgery; 2009 Jul; 146(1):12-7. PubMed ID: 19541005
[TBL] [Abstract][Full Text] [Related]
35. Pathogenesis of postoperative adhesion formation.
Hellebrekers BW; Kooistra T
Br J Surg; 2011 Nov; 98(11):1503-16. PubMed ID: 21877324
[TBL] [Abstract][Full Text] [Related]
36. Effects of octreotide on epidermal growth factor receptor, tissue plasminogen activator, and plasminogen activator inhibitor during intraperitoneal adhesion formation.
Lai HS; Chen Y; Chang KJ; Chen WJ
J Gastroenterol; 2003; 38(6):555-60. PubMed ID: 12825131
[TBL] [Abstract][Full Text] [Related]
37. Tissue markers as predictors of postoperative adhesions.
Ivarsson ML; Bergström M; Eriksson E; Risberg B; Holmdahl L
Br J Surg; 1998 Nov; 85(11):1549-54. PubMed ID: 9823923
[TBL] [Abstract][Full Text] [Related]
38. Peritoneal fibrinolysis: evidence for the efficiency of the tissue-type plasminogen activator.
Moore KL; Bang NU; Broadie TA; Mattler LE; Marks CA
J Lab Clin Med; 1983 Jun; 101(6):921-9. PubMed ID: 6682880
[TBL] [Abstract][Full Text] [Related]
39. [Peritoneal adhesions: pathophysiology].
Fabiano G; Pezzolla A; Maiorino R; Ferrarese F
G Chir; 2008 Mar; 29(3):115-25. PubMed ID: 18366893
[TBL] [Abstract][Full Text] [Related]
40. Peritoneal fibrinolytic activity in peritonitis.
Ince A; Eroglu A; Tarhan O; Bülbül M
Am J Surg; 2002 Jan; 183(1):67-9. PubMed ID: 11869706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
